Real-World Experience with Ceftolozane-Tazobactam for Multidrug-Resistant Gram-Negative Bacterial Infections

Our objective was to describe the prescribing practices, clinical characteristics, and outcomes of patients treated with ceftolozane-tazobactam (C/T) for multidrug-resistant (MDR) Gram-negative infections. This was a multicenter, retrospective, cohort study at eight U.S. medical centers (2015 to 201...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Antimicrob Agents Chemother
Huvudupphovsmän: Jorgensen, Sarah C. J., Trinh, Trang D., Zasowski, Evan J., Lagnf, Abdalhamid M., Simon, Samuel P., Bhatia, Sahil, Melvin, Sarah M., Steed, Molly E., Finch, Natalie A., Morrisette, Taylor, Estrada, Sandy J., Rosenberg, Joshua R., Davis, Susan L., Rybak, Michael J.
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Society for Microbiology 2020
Ämnen:
Clinical Therapeutics
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7179316/
https://ncbi.nlm.nih.gov/pubmed/31932379
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02291-19
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk